Hematology-Oncology | sciencenewsnet.in

Breaking News

Survey of U.S. Parents Highlights Need for More Awareness About Newborn Screening, Cystic Fibrosis and What to Do if Results are Abnormal

American Association of Immunologists (AAI) Introduces New Brand Identity

Stony coral tissue loss disease is shifting the ecological balance of Caribbean reefs

Metastatic Prostate Cancer Research: PSMAfore follow-on study favors radioligand therapy over change to androgen receptor pathway inhibition

May is Mental Health Awareness Month. Experts and Patients Available for Interviews on Trending Issues

ChatGPT can be helpful for Black women’s self-education about HIV, PrEP

Tip Sheet: Funding awarded to two ovarian cancer research projects, progress towards liquid biopsies for lung cancer — and cannabis and alcohol use in patients

A Revolution In Gene Therapy Is Unfolding, Bringing Hope for Vision Loss

Mexican researchers have found that people who avoid going to psychologists choose the most violent suicide methods

Genetics, not lack of oxygen, causes cerebral palsy in quarter of cases

06 May, 2024

Drug targeting clear cell renal cell carcinoma shows promising approach

April 23, 2024 sarah JonasResearch Results

In a groundbreaking phase one clinical trial led by UT Southwestern Medical Center, a short interfering RNA (siRNA) drug directed to tumor cells effectively disrupted HIF2α, a key driver of clear cell renal cell carcinoma (ccRCC). Published in Clinical Cancer Research, the findings illustrate the potential of siRNA for cancer therapy.